XML 67 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Combination - Intangible Assets Acquired (Details) - Antares Pharma, Inc
$ in Thousands
19 Months Ended
Dec. 31, 2023
USD ($)
Business Acquisition [Line Items]  
Fair value of intangible assets acquired $ 589,800
ATRS-1902 (IPR&D)  
Business Acquisition [Line Items]  
Indefinite-lived intangible assets acquired 48,700
Auto-Injector technology platform  
Business Acquisition [Line Items]  
Finite-lived intangible assets acquired $ 402,000
Useful life (years) 7 years
XYOSTED proprietary product  
Business Acquisition [Line Items]  
Finite-lived intangible assets acquired $ 136,200
Useful life (years) 10 years
TLANDO product rights  
Business Acquisition [Line Items]  
Finite-lived intangible assets acquired $ 2,900
Useful life (years) 10 years